SUZANO SA - SPON ADR (SUZ) Fundamental Analysis & Valuation

NYSE:SUZUS86959K1051

Current stock price

9.1 USD
-0.25 (-2.67%)
At close:
9.13 USD
+0.03 (+0.33%)
After Hours:

This SUZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. SUZ Profitability Analysis

1.1 Basic Checks

  • SUZ had positive earnings in the past year.
  • In the past year SUZ had a positive cash flow from operations.
  • Of the past 5 years SUZ 4 years were profitable.
  • In the past 5 years SUZ always reported a positive cash flow from operatings.
SUZ Yearly Net Income VS EBIT VS OCF VS FCFSUZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B

1.2 Ratios

  • SUZ has a better Return On Assets (7.98%) than 100.00% of its industry peers.
  • SUZ has a Return On Equity of 30.60%. This is amongst the best in the industry. SUZ outperforms 100.00% of its industry peers.
  • SUZ has a better Return On Invested Capital (4.24%) than 77.78% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for SUZ is in line with the industry average of 4.99%.
Industry RankSector Rank
ROA 7.98%
ROE 30.6%
ROIC 4.24%
ROA(3y)4.51%
ROA(5y)7.67%
ROE(3y)13.4%
ROE(5y)33.63%
ROIC(3y)5.46%
ROIC(5y)7.6%
SUZ Yearly ROA, ROE, ROICSUZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

1.3 Margins

  • SUZ has a Profit Margin of 26.75%. This is amongst the best in the industry. SUZ outperforms 100.00% of its industry peers.
  • In the last couple of years the Profit Margin of SUZ has declined.
  • Looking at the Operating Margin, with a value of 19.81%, SUZ belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of SUZ has declined.
  • Looking at the Gross Margin, with a value of 32.38%, SUZ belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • SUZ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 19.81%
PM (TTM) 26.75%
GM 32.38%
OM growth 3Y-21.92%
OM growth 5Y-5.67%
PM growth 3Y-17.08%
PM growth 5YN/A
GM growth 3Y-13.59%
GM growth 5Y-3.18%
SUZ Yearly Profit, Operating, Gross MarginsSUZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

5

2. SUZ Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SUZ is destroying value.
  • SUZ has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SUZ has less shares outstanding
  • SUZ has a better debt/assets ratio than last year.
SUZ Yearly Shares OutstandingSUZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SUZ Yearly Total Debt VS Total AssetsSUZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • Based on the Altman-Z score of 1.15, we must say that SUZ is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of SUZ (1.15) is worse than 66.67% of its industry peers.
  • SUZ has a debt to FCF ratio of 19.28. This is a negative value and a sign of low solvency as SUZ would need 19.28 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 19.28, SUZ is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • SUZ has a Debt/Equity ratio of 2.23. This is a high value indicating a heavy dependency on external financing.
  • SUZ has a Debt to Equity ratio of 2.23. This is in the lower half of the industry: SUZ underperforms 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.23
Debt/FCF 19.28
Altman-Z 1.15
ROIC/WACC0.75
WACC5.69%
SUZ Yearly LT Debt VS Equity VS FCFSUZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B 80B

2.3 Liquidity

  • SUZ has a Current Ratio of 3.19. This indicates that SUZ is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.19, SUZ belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • SUZ has a Quick Ratio of 2.59. This indicates that SUZ is financially healthy and has no problem in meeting its short term obligations.
  • SUZ's Quick ratio of 2.59 is amongst the best of the industry. SUZ outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 2.59
SUZ Yearly Current Assets VS Current LiabilitesSUZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

5

3. SUZ Growth Analysis

3.1 Past

  • SUZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 298.21%, which is quite impressive.
  • Measured over the past years, SUZ shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -14.55% on average per year.
  • The Revenue has been growing slightly by 5.72% in the past year.
  • SUZ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.47% yearly.
EPS 1Y (TTM)298.21%
EPS 3Y-14.55%
EPS 5YN/A
EPS Q2Q%104.82%
Revenue 1Y (TTM)5.72%
Revenue growth 3Y0.19%
Revenue growth 5Y10.47%
Sales Q2Q%-7.5%

3.2 Future

  • The Earnings Per Share is expected to decrease by -17.43% on average over the next years. This is quite bad
  • SUZ is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.01% yearly.
EPS Next Y-46.07%
EPS Next 2Y-21.96%
EPS Next 3Y-17.43%
EPS Next 5YN/A
Revenue Next Year11.61%
Revenue Next 2Y12.59%
Revenue Next 3Y9.78%
Revenue Next 5Y11.01%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SUZ Yearly Revenue VS EstimatesSUZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B 80B
SUZ Yearly EPS VS EstimatesSUZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 10 -10

7

4. SUZ Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 4.14 indicates a rather cheap valuation of SUZ.
  • SUZ's Price/Earnings ratio is rather cheap when compared to the industry. SUZ is cheaper than 100.00% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of SUZ to the average of the S&P500 Index (27.42), we can say SUZ is valued rather cheaply.
  • The Price/Forward Earnings ratio is 7.68, which indicates a rather cheap valuation of SUZ.
  • SUZ's Price/Forward Earnings ratio is rather cheap when compared to the industry. SUZ is cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.24, SUZ is valued rather cheaply.
Industry RankSector Rank
PE 4.14
Fwd PE 7.68
SUZ Price Earnings VS Forward Price EarningsSUZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SUZ is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, SUZ is valued a bit cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.66
EV/EBITDA 5.79
SUZ Per share dataSUZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • SUZ has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as SUZ's earnings are expected to decrease with -17.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.96%
EPS Next 3Y-17.43%

3

5. SUZ Dividend Analysis

5.1 Amount

  • SUZ has a yearly dividend return of 0.45%, which is pretty low.
  • SUZ's Dividend Yield is comparable with the industry average which is at 1.73.
  • With a Dividend Yield of 0.45, SUZ pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.45%

5.2 History

  • SUZ has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
SUZ Yearly Dividends per shareSUZ Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • 16.47% of the earnings are spent on dividend by SUZ. This is a low number and sustainable payout ratio.
DP16.47%
EPS Next 2Y-21.96%
EPS Next 3Y-17.43%
SUZ Yearly Income VS Free CF VS DividendSUZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B
SUZ Dividend Payout.SUZ Dividend Payout, showing the Payout Ratio.SUZ Dividend Payout.PayoutRetained Earnings

SUZ Fundamentals: All Metrics, Ratios and Statistics

SUZANO SA - SPON ADR

NYSE:SUZ (4/24/2026, 8:09:54 PM)

After market: 9.13 +0.03 (+0.33%)

9.1

-0.25 (-2.67%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)02-10
Earnings (Next)04-29
Inst Owners38.32%
Inst Owner Change-0.79%
Ins Owners15.51%
Ins Owner Change0%
Market Cap11.25B
Revenue(TTM)50.12B
Net Income(TTM)13.41B
Analysts84.55
Price Target13.73 (50.88%)
Short Float %1.73%
Short Ratio2.79
Dividend
Industry RankSector Rank
Dividend Yield 0.45%
Yearly Dividend0.36
Dividend Growth(5Y)N/A
DP16.47%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)72.56%
Min EPS beat(2)9.47%
Max EPS beat(2)135.65%
EPS beat(4)4
Avg EPS beat(4)88.67%
Min EPS beat(4)9.47%
Max EPS beat(4)196.69%
EPS beat(8)6
Avg EPS beat(8)-51.25%
EPS beat(12)9
Avg EPS beat(12)-26.17%
EPS beat(16)12
Avg EPS beat(16)-18.47%
Revenue beat(2)1
Avg Revenue beat(2)-0.1%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)1.72%
Revenue beat(4)2
Avg Revenue beat(4)-1.48%
Min Revenue beat(4)-6.63%
Max Revenue beat(4)1.72%
Revenue beat(8)4
Avg Revenue beat(8)-1.04%
Revenue beat(12)6
Avg Revenue beat(12)-0.88%
Revenue beat(16)9
Avg Revenue beat(16)-0.42%
PT rev (1m)2.8%
PT rev (3m)-0.21%
EPS NQ rev (1m)-33.06%
EPS NQ rev (3m)58.99%
EPS NY rev (1m)-0.2%
EPS NY rev (3m)-1.02%
Revenue NQ rev (1m)-5.73%
Revenue NQ rev (3m)-1.45%
Revenue NY rev (1m)-0.3%
Revenue NY rev (3m)-0.81%
Valuation
Industry RankSector Rank
PE 4.14
Fwd PE 7.68
P/S 1.12
P/FCF 10.66
P/OCF 3.1
P/B 1.28
P/tB 1.82
EV/EBITDA 5.79
EPS(TTM)2.2
EY24.18%
EPS(NY)1.18
Fwd EY13.02%
FCF(TTM)0.85
FCFY9.38%
OCF(TTM)2.94
OCFY32.27%
SpS8.11
BVpS7.09
TBVpS4.99
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.7311 (105.84%)
Profitability
Industry RankSector Rank
ROA 7.98%
ROE 30.6%
ROCE 6.44%
ROIC 4.24%
ROICexc 5.06%
ROICexgc 5.63%
OM 19.81%
PM (TTM) 26.75%
GM 32.38%
FCFM 10.53%
ROA(3y)4.51%
ROA(5y)7.67%
ROE(3y)13.4%
ROE(5y)33.63%
ROIC(3y)5.46%
ROIC(5y)7.6%
ROICexc(3y)6.5%
ROICexc(5y)9.16%
ROICexgc(3y)7.38%
ROICexgc(5y)10.77%
ROCE(3y)8.29%
ROCE(5y)11.54%
ROICexgc growth 3Y-29.09%
ROICexgc growth 5Y-6.41%
ROICexc growth 3Y-27.76%
ROICexc growth 5Y-4.23%
OM growth 3Y-21.92%
OM growth 5Y-5.67%
PM growth 3Y-17.08%
PM growth 5YN/A
GM growth 3Y-13.59%
GM growth 5Y-3.18%
F-Score8
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 2.23
Debt/FCF 19.28
Debt/EBITDA 4.61
Cap/Depr 113.96%
Cap/Sales 25.69%
Interest Coverage 1.71
Cash Conversion 85.52%
Profit Quality 39.36%
Current Ratio 3.19
Quick Ratio 2.59
Altman-Z 1.15
F-Score8
WACC5.69%
ROIC/WACC0.75
Cap/Depr(3y)181.88%
Cap/Depr(5y)168.52%
Cap/Sales(3y)35.7%
Cap/Sales(5y)30.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)298.21%
EPS 3Y-14.55%
EPS 5YN/A
EPS Q2Q%104.82%
EPS Next Y-46.07%
EPS Next 2Y-21.96%
EPS Next 3Y-17.43%
EPS Next 5YN/A
Revenue 1Y (TTM)5.72%
Revenue growth 3Y0.19%
Revenue growth 5Y10.47%
Sales Q2Q%-7.5%
Revenue Next Year11.61%
Revenue Next 2Y12.59%
Revenue Next 3Y9.78%
Revenue Next 5Y11.01%
EBIT growth 1Y-31.23%
EBIT growth 3Y-21.77%
EBIT growth 5Y4.21%
EBIT Next Year148.67%
EBIT Next 3Y43.29%
EBIT Next 5Y26.82%
FCF growth 1Y39.75%
FCF growth 3Y-6.45%
FCF growth 5Y-8.5%
OCF growth 1Y-11.9%
OCF growth 3Y-5.69%
OCF growth 5Y6.7%

SUZANO SA - SPON ADR / SUZ Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SUZANO SA - SPON ADR (SUZ) stock?

ChartMill assigns a fundamental rating of 6 / 10 to SUZ.


Can you provide the valuation status for SUZANO SA - SPON ADR?

ChartMill assigns a valuation rating of 7 / 10 to SUZANO SA - SPON ADR (SUZ). This can be considered as Undervalued.


How profitable is SUZANO SA - SPON ADR (SUZ) stock?

SUZANO SA - SPON ADR (SUZ) has a profitability rating of 7 / 10.


What are the PE and PB ratios of SUZANO SA - SPON ADR (SUZ) stock?

The Price/Earnings (PE) ratio for SUZANO SA - SPON ADR (SUZ) is 4.14 and the Price/Book (PB) ratio is 1.28.


What is the financial health of SUZANO SA - SPON ADR (SUZ) stock?

The financial health rating of SUZANO SA - SPON ADR (SUZ) is 5 / 10.